Loading market dashboard
Enhabit, Inc.
EHABHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the company's acquisition by Kinderhook Industries. Clift succeeds Barb Jacobsmeyer, former president and CEO of Enhabit, who previously announced her intention to step down upon the appointment of a successor. Clift brings decades of leadership experience in home health and hospice care. He previously se.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Enhabit, Inc. (NYSE: EHAB - Get Free Report) has been given a consensus recommendation of "Hold" by the nine ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating on the company. The average
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders (the “Special Meeting”) on May 12, 2026, at 8 a.m. CDT, to vote on the previously announced agreement and plan of merger (the “Merger Agreement”). Pursuant to the Merger Agreement, Anchor Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Anchor Parent, LLC (“.
JPMorgan Chase and Co. lowered its holdings in shares of Enhabit, Inc. (NYSE: EHAB) by 48.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 291,823 shares of the company's stock after selling 271,731 shares during the period. JPMorgan
Selectis Health (OTCMKTS:GBCS - Get Free Report) and Enhabit (NYSE: EHAB - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Analyst Recommendations This is a breakdown of current
8 Knots Management LLC boosted its stake in shares of Enhabit, Inc. (NYSE: EHAB) by 9.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,218,846 shares of the company's stock after purchasing an additional 365,779 shares during the quarter. Enhabit comprises 3.8%
Dynamic Technology Lab Private Ltd reduced its holdings in shares of Enhabit, Inc. (NYSE: EHAB) by 57.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,541 shares of the company's stock after selling 42,823 shares during the period.
With the CBOE Volatility Index (VIX) sitting at 25.50 and up 34.9% over the past month, investors are increasingly rotating toward names that offer stability, predictable income, and low correlation to broader market swings.
Enhabit (NYSE: EHAB - Get Free Report) and Agilon Health (NYSE: AGL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Analyst Ratings This is a breakdown of current
